Bitopertin (GLYT-1; RO-4917838; RG1678) is a drug under development intended to be used in combination with antipsychotics for the treatment of persistent negative symptoms or sub-optimally controlled positive symptoms associated with schizophrenia.
This page contains content from the copyrighted Wikipedia article "Bitopertin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.